Here's Why I'd Sell Nebius Stock and Buy Astera Labs Instead

Nebius is described as a legitimate AI cloud business, but its valuation is cited at roughly 99x trailing price-to-sales on about $530 million of revenue, with shares up more than 522% over the past year. The article favors Astera Labs, which reported Q1 2026 revenue of $308.4 million, up 93% year over year and 14% sequentially, with GAAP gross margin of 76.3%, operating income of $61.8 million, and net income of $80.3 million. Astera also guided Q2 revenue to $355 million-$365 million versus $310 million consensus and highlighted shipping of its Scorpio X 320-lane Smart Fabric Switch.

Analysis

The market is increasingly bifurcating AI winners into two buckets: cash-burning “land grab” platforms priced for flawless long-duration growth, and picks-and-shovels infrastructure with present-day earnings power. That matters because once sentiment rotates from narrative scarcity to execution scrutiny, the first group typically de-rates before fundamentals deteriorate. In that regime, the best relative longs are not the highest-growth names, but the ones where revenue visibility is already translating into operating leverage.

Nebius looks vulnerable to a valuation-compression trade rather than a fundamentals short. The second-order risk is that every incremental dollar of capex and capacity expansion raises the burden of proof on utilization and customer concentration; if growth is merely good instead of exceptional, the equity can still underperform for quarters even while the business improves. By contrast, Astera’s product mix gives it more leverage to the AI buildout without needing perfect macro conditions, and the current profitability means the stock can absorb a slower ramp without immediately rerating lower on cash burn.

The key contrarian point is that the market may be overpricing “GPU cloud” scarcity while underpricing the bottleneck around interconnect density, signal integrity, and cluster management. As AI systems scale, the winners may shift from headline compute providers to enabling components that capture a larger share of the incremental dollar of spend per rack. That creates a cleaner relative-value setup: you do not need to be bullish on all of AI, only on continued rack-level complexity.

Near term, NBIS can keep working if management prints repeated upside and avoids any hint of capacity slippage; over a 6–12 month horizon, however, the risk/reward skews against paying venture multiples for infrastructure buildout. ALAB’s risk is more idiosyncratic—customer concentration and possible in-house substitution—but those are visible and should be monitored through order cadence rather than headline sentiment. The setup favors owning the company with current earnings and shorting the one where the valuation already assumes the next several execution milestones are unavoidable.

Key Decisions for Investors

• Rotate from NBIS into ALAB on any post-earnings volatility: long ALAB / short NBIS as a 3-6 month relative-value pair; thesis is multiple compression in NBIS versus earnings support in ALAB.
• If initiating fresh exposure to AI infrastructure, prefer ALAB common over NBIS common for the next 2 quarters: better downside capture if AI sentiment cools, with operating leverage still intact.
• Use options to express the valuation view: buy 6-9 month put spreads on NBIS sized to a 20-25% drawdown target, funded partially by selling out-of-the-money calls if liquidity allows.
• Add ALAB on pullbacks after guidance-driven spikes rather than chase strength; entry discipline should target a 5-10% retrace because the bull case is already partly priced, but less precariously than NBIS.
• Monitor AMZN capex commentary and custom silicon disclosures as the primary catalyst/risk over the next 1-2 quarters; if hyperscalers internalize more of the interconnect stack, trim ALAB, but if complexity keeps rising, add on confirmation.